nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—Ischaemic stroke—Ramipril—type 1 diabetes mellitus	0.0784	0.142	CcSEcCtD
Sitaxentan—Blood potassium increased—Ramipril—type 1 diabetes mellitus	0.0299	0.0543	CcSEcCtD
Sitaxentan—Lower respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.0265	0.048	CcSEcCtD
Sitaxentan—White blood cell count decreased—Ramipril—type 1 diabetes mellitus	0.0182	0.0329	CcSEcCtD
Sitaxentan—Psoriasis—Ramipril—type 1 diabetes mellitus	0.0144	0.0261	CcSEcCtD
Sitaxentan—Endocrine disorder—Ramipril—type 1 diabetes mellitus	0.0109	0.0198	CcSEcCtD
Sitaxentan—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.0104	0.0189	CcSEcCtD
Sitaxentan—Proteinuria—Ramipril—type 1 diabetes mellitus	0.0103	0.0187	CcSEcCtD
Sitaxentan—Protein urine present—Ramipril—type 1 diabetes mellitus	0.0101	0.0184	CcSEcCtD
Sitaxentan—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.00758	0.0137	CcSEcCtD
Sitaxentan—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.0074	0.0134	CcSEcCtD
Sitaxentan—Deafness—Ramipril—type 1 diabetes mellitus	0.00734	0.0133	CcSEcCtD
Sitaxentan—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.0073	0.0132	CcSEcCtD
Sitaxentan—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.0072	0.0131	CcSEcCtD
Sitaxentan—Renal impairment—Ramipril—type 1 diabetes mellitus	0.0069	0.0125	CcSEcCtD
Sitaxentan—Arthritis—Ramipril—type 1 diabetes mellitus	0.00675	0.0122	CcSEcCtD
Sitaxentan—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.00672	0.0122	CcSEcCtD
Sitaxentan—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.00672	0.0122	CcSEcCtD
Sitaxentan—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.00615	0.0111	CcSEcCtD
Sitaxentan—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00606	0.011	CcSEcCtD
Sitaxentan—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00599	0.0109	CcSEcCtD
Sitaxentan—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.00599	0.0109	CcSEcCtD
Sitaxentan—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00593	0.0108	CcSEcCtD
Sitaxentan—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.00591	0.0107	CcSEcCtD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—CCL20—type 1 diabetes mellitus	0.00584	0.013	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—CCL11—type 1 diabetes mellitus	0.00584	0.013	CbGpPWpGaD
Sitaxentan—Asthma—Ramipril—type 1 diabetes mellitus	0.00567	0.0103	CcSEcCtD
Sitaxentan—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00562	0.0102	CcSEcCtD
Sitaxentan—EDNRB—Peptide GPCRs—CCR5—type 1 diabetes mellitus	0.00555	0.0124	CbGpPWpGaD
Sitaxentan—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00552	0.01	CcSEcCtD
Sitaxentan—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00545	0.00989	CcSEcCtD
Sitaxentan—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00544	0.00986	CcSEcCtD
Sitaxentan—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00539	0.00977	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00518	0.00939	CcSEcCtD
Sitaxentan—EDNRA—Endothelin Pathways—NOS3—type 1 diabetes mellitus	0.00516	0.0115	CbGpPWpGaD
Sitaxentan—EDNRB—G alpha (q) signalling events—ITPR3—type 1 diabetes mellitus	0.00499	0.0111	CbGpPWpGaD
Sitaxentan—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00498	0.00904	CcSEcCtD
Sitaxentan—Renal failure—Ramipril—type 1 diabetes mellitus	0.00497	0.00901	CcSEcCtD
Sitaxentan—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00496	0.00899	CcSEcCtD
Sitaxentan—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00493	0.00894	CcSEcCtD
Sitaxentan—Jaundice—Ramipril—type 1 diabetes mellitus	0.00493	0.00894	CcSEcCtD
Sitaxentan—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00492	0.00891	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.00478	0.00867	CcSEcCtD
Sitaxentan—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00477	0.00865	CcSEcCtD
Sitaxentan—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00474	0.0086	CcSEcCtD
Sitaxentan—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00454	0.00823	CcSEcCtD
Sitaxentan—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00447	0.00811	CcSEcCtD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR3—type 1 diabetes mellitus	0.00447	0.00996	CbGpPWpGaD
Sitaxentan—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00437	0.00793	CcSEcCtD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.0043	0.00959	CbGpPWpGaD
Sitaxentan—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00423	0.00767	CcSEcCtD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—GAL—type 1 diabetes mellitus	0.00423	0.00943	CbGpPWpGaD
Sitaxentan—Flushing—Ramipril—type 1 diabetes mellitus	0.00421	0.00764	CcSEcCtD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—CCL11—type 1 diabetes mellitus	0.00418	0.00932	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—CCL20—type 1 diabetes mellitus	0.00418	0.00932	CbGpPWpGaD
Sitaxentan—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.0041	0.00743	CcSEcCtD
Sitaxentan—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00409	0.00742	CcSEcCtD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—SST—type 1 diabetes mellitus	0.00405	0.00903	CbGpPWpGaD
Sitaxentan—Alopecia—Ramipril—type 1 diabetes mellitus	0.00401	0.00727	CcSEcCtD
Sitaxentan—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00398	0.00721	CcSEcCtD
Sitaxentan—EDNRA—Peptide GPCRs—CCR5—type 1 diabetes mellitus	0.00397	0.00885	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.00396	0.00884	CbGpPWpGaD
Sitaxentan—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00395	0.00716	CcSEcCtD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.00392	0.00874	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.00392	0.00874	CbGpPWpGaD
Sitaxentan—Tension—Ramipril—type 1 diabetes mellitus	0.00388	0.00703	CcSEcCtD
Sitaxentan—Nervousness—Ramipril—type 1 diabetes mellitus	0.00384	0.00696	CcSEcCtD
Sitaxentan—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.0038	0.00689	CcSEcCtD
Sitaxentan—Tremor—Ramipril—type 1 diabetes mellitus	0.0037	0.00671	CcSEcCtD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.00368	0.00821	CbGpPWpGaD
Sitaxentan—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00367	0.00665	CcSEcCtD
Sitaxentan—EDNRB—G alpha (q) signalling events—GCG—type 1 diabetes mellitus	0.00365	0.00815	CbGpPWpGaD
Sitaxentan—Agitation—Ramipril—type 1 diabetes mellitus	0.00363	0.00658	CcSEcCtD
Sitaxentan—EDNRA—G alpha (q) signalling events—ITPR3—type 1 diabetes mellitus	0.00357	0.00797	CbGpPWpGaD
Sitaxentan—Malaise—Ramipril—type 1 diabetes mellitus	0.00356	0.00646	CcSEcCtD
Sitaxentan—Vertigo—Ramipril—type 1 diabetes mellitus	0.00355	0.00644	CcSEcCtD
Sitaxentan—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00354	0.00641	CcSEcCtD
Sitaxentan—EDNRB—G alpha (q) signalling events—PRKCQ—type 1 diabetes mellitus	0.00352	0.00784	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Other—CCR5—type 1 diabetes mellitus	0.00336	0.0075	CbGpPWpGaD
Sitaxentan—Chest pain—Ramipril—type 1 diabetes mellitus	0.00336	0.0061	CcSEcCtD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—CXCL10—type 1 diabetes mellitus	0.00336	0.0075	CbGpPWpGaD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00334	0.00606	CcSEcCtD
Sitaxentan—Discomfort—Ramipril—type 1 diabetes mellitus	0.00332	0.00603	CcSEcCtD
Sitaxentan—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00329	0.00597	CcSEcCtD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 1 diabetes mellitus	0.00327	0.00729	CbGpPWpGaD
Sitaxentan—Confusional state—Ramipril—type 1 diabetes mellitus	0.00325	0.0059	CcSEcCtD
Sitaxentan—Oedema—Ramipril—type 1 diabetes mellitus	0.00323	0.00585	CcSEcCtD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR3—type 1 diabetes mellitus	0.0032	0.00713	CbGpPWpGaD
Sitaxentan—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00316	0.00573	CcSEcCtD
Sitaxentan—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00316	0.00573	CcSEcCtD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.00316	0.00704	CbGpPWpGaD
Sitaxentan—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00315	0.00571	CcSEcCtD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—type 1 diabetes mellitus	0.00315	0.00702	CbGpPWpGaD
Sitaxentan—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00313	0.00568	CcSEcCtD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.00308	0.00686	CbGpPWpGaD
Sitaxentan—Anorexia—Ramipril—type 1 diabetes mellitus	0.00307	0.00557	CcSEcCtD
Sitaxentan—CYP2C19—Melatonin metabolism and effects—ADRB1—type 1 diabetes mellitus	0.00306	0.00683	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.00302	0.00673	CbGpPWpGaD
Sitaxentan—Hypotension—Ramipril—type 1 diabetes mellitus	0.00301	0.00546	CcSEcCtD
Sitaxentan—EDNRB—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00298	0.00665	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00298	0.00665	CbGpPWpGaD
Sitaxentan—Insomnia—Ramipril—type 1 diabetes mellitus	0.00292	0.00529	CcSEcCtD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—SST—type 1 diabetes mellitus	0.0029	0.00646	CbGpPWpGaD
Sitaxentan—Somnolence—Ramipril—type 1 diabetes mellitus	0.00287	0.0052	CcSEcCtD
Sitaxentan—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00284	0.00515	CcSEcCtD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.00284	0.00632	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00281	0.00626	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.0028	0.00625	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.0028	0.00625	CbGpPWpGaD
Sitaxentan—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.0028	0.00508	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00278	0.00505	CcSEcCtD
Sitaxentan—Fatigue—Ramipril—type 1 diabetes mellitus	0.00278	0.00504	CcSEcCtD
Sitaxentan—Constipation—Ramipril—type 1 diabetes mellitus	0.00276	0.005	CcSEcCtD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00272	0.00606	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.0027	0.00603	CbGpPWpGaD
Sitaxentan—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00266	0.00482	CcSEcCtD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.00264	0.00588	CbGpPWpGaD
Sitaxentan—EDNRA—G alpha (q) signalling events—GCG—type 1 diabetes mellitus	0.00262	0.00583	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—CCR5—type 1 diabetes mellitus	0.00261	0.00582	CbGpPWpGaD
Sitaxentan—Urticaria—Ramipril—type 1 diabetes mellitus	0.00256	0.00465	CcSEcCtD
Sitaxentan—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00255	0.00462	CcSEcCtD
Sitaxentan—EDNRA—G alpha (q) signalling events—PRKCQ—type 1 diabetes mellitus	0.00252	0.00561	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—CXCL10—type 1 diabetes mellitus	0.00241	0.00537	CbGpPWpGaD
Sitaxentan—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00238	0.00431	CcSEcCtD
Sitaxentan—EDNRB—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00236	0.00525	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 1 diabetes mellitus	0.00234	0.00522	CbGpPWpGaD
Sitaxentan—Asthenia—Ramipril—type 1 diabetes mellitus	0.00231	0.0042	CcSEcCtD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.00226	0.00504	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00226	0.00503	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—type 1 diabetes mellitus	0.00225	0.00502	CbGpPWpGaD
Sitaxentan—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00221	0.004	CcSEcCtD
Sitaxentan—EDNRA—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.00216	0.00482	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00214	0.00476	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00214	0.00476	CbGpPWpGaD
Sitaxentan—Dizziness—Ramipril—type 1 diabetes mellitus	0.00213	0.00387	CcSEcCtD
Sitaxentan—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—type 1 diabetes mellitus	0.00208	0.00463	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00207	0.00461	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00206	0.00459	CbGpPWpGaD
Sitaxentan—Vomiting—Ramipril—type 1 diabetes mellitus	0.00205	0.00372	CcSEcCtD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00204	0.00455	CbGpPWpGaD
Sitaxentan—Rash—Ramipril—type 1 diabetes mellitus	0.00203	0.00369	CcSEcCtD
Sitaxentan—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00203	0.00368	CcSEcCtD
Sitaxentan—Headache—Ramipril—type 1 diabetes mellitus	0.00202	0.00366	CcSEcCtD
Sitaxentan—EDNRA—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00201	0.00448	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00194	0.00433	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00194	0.00431	CbGpPWpGaD
Sitaxentan—Nausea—Ramipril—type 1 diabetes mellitus	0.00192	0.00347	CcSEcCtD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—CCR5—type 1 diabetes mellitus	0.00187	0.00416	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00184	0.00411	CbGpPWpGaD
Sitaxentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.00181	0.00403	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00175	0.0039	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00172	0.00383	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00171	0.0038	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00169	0.00376	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00169	0.00376	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—type 1 diabetes mellitus	0.00164	0.00366	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00161	0.0036	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00159	0.00353	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00155	0.00345	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00153	0.00341	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00153	0.00341	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00148	0.0033	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00147	0.00329	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00146	0.00326	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00144	0.00321	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00142	0.00317	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.00133	0.00297	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.00133	0.00297	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00132	0.00294	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.00129	0.00288	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00125	0.00279	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00123	0.00274	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00122	0.00272	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00121	0.0027	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00121	0.00269	CbGpPWpGaD
Sitaxentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.00119	0.00266	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—type 1 diabetes mellitus	0.00117	0.00262	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.00117	0.00261	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00116	0.00259	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00113	0.00253	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00111	0.00247	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.0011	0.00244	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.0011	0.00244	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—SST—type 1 diabetes mellitus	0.00106	0.00237	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.00106	0.00236	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	0.00104	0.00233	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.00104	0.00232	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00103	0.0023	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00102	0.00227	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.001	0.00224	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000974	0.00217	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000971	0.00217	CbGpPWpGaD
Sitaxentan—CYP3A4—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.000965	0.00215	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000954	0.00213	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000953	0.00212	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000946	0.00211	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000925	0.00206	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000915	0.00204	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000911	0.00203	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000904	0.00202	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000904	0.00202	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000884	0.00197	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000882	0.00197	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000865	0.00193	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.00085	0.0019	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000836	0.00187	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000833	0.00186	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000828	0.00185	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.000803	0.00179	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000763	0.0017	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—SST—type 1 diabetes mellitus	0.00076	0.00169	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000756	0.00169	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000755	0.00168	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000753	0.00168	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	0.000747	0.00167	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000746	0.00166	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000742	0.00166	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000719	0.0016	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000718	0.0016	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000714	0.00159	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000714	0.00159	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000697	0.00155	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000695	0.00155	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000684	0.00152	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000677	0.00151	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000674	0.0015	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000655	0.00146	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000652	0.00145	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000647	0.00144	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000647	0.00144	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000633	0.00141	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000631	0.00141	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—SST—type 1 diabetes mellitus	0.000627	0.0014	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000624	0.00139	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000609	0.00136	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.000574	0.00128	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000559	0.00125	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000546	0.00122	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000539	0.0012	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000538	0.0012	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000531	0.00118	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000522	0.00116	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000521	0.00116	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000514	0.00115	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000511	0.00114	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000511	0.00114	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000498	0.00111	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000489	0.00109	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000482	0.00108	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000475	0.00106	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000473	0.00105	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000456	0.00102	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SST—type 1 diabetes mellitus	0.000449	0.001	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000447	0.000996	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000435	0.00097	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000432	0.000964	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000411	0.000916	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000404	0.000901	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—GCG—type 1 diabetes mellitus	0.0004	0.000892	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000398	0.000888	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000395	0.000881	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000385	0.000858	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000374	0.000834	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000373	0.000831	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.00034	0.000758	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000339	0.000755	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000332	0.000741	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000326	0.000727	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000324	0.000722	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—INS—type 1 diabetes mellitus	0.000314	0.0007	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000311	0.000694	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000309	0.00069	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000304	0.000677	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000302	0.000674	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000295	0.000658	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000294	0.000656	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000289	0.000645	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000285	0.000635	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HBA2—type 1 diabetes mellitus	0.000283	0.000632	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000283	0.000631	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000281	0.000626	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000275	0.000614	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—G6PC2—type 1 diabetes mellitus	0.000267	0.000594	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HBA2—type 1 diabetes mellitus	0.000258	0.000576	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—G6PC2—type 1 diabetes mellitus	0.000243	0.000542	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000238	0.00053	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000234	0.000521	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000233	0.000521	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000232	0.000518	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ABCC8—type 1 diabetes mellitus	0.000231	0.000515	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—INS—type 1 diabetes mellitus	0.000225	0.000501	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000217	0.000485	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000216	0.000482	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	0.000211	0.00047	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000201	0.000448	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000197	0.000439	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000196	0.000438	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000183	0.000407	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000179	0.000398	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	0.00017	0.00038	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000167	0.000373	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000167	0.000373	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000167	0.000371	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000166	0.000371	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	0.00016	0.000357	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ITPR3—type 1 diabetes mellitus	0.000154	0.000344	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HBA1—type 1 diabetes mellitus	0.000145	0.000324	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—APOC3—type 1 diabetes mellitus	0.000144	0.000322	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTT1—type 1 diabetes mellitus	0.000142	0.000316	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	0.000141	0.000313	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000141	0.000313	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	0.000139	0.00031	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL6—type 1 diabetes mellitus	0.000137	0.000306	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	0.000132	0.000295	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	0.000131	0.000293	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000131	0.000291	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	0.000129	0.000288	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000128	0.000285	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000119	0.000265	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GCG—type 1 diabetes mellitus	0.000113	0.000252	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	0.00011	0.000245	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	0.000103	0.000229	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL6—type 1 diabetes mellitus	9.82e-05	0.000219	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	9.55e-05	0.000213	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	9.27e-05	0.000207	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	8.73e-05	0.000195	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	8.71e-05	0.000194	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	8.67e-05	0.000193	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	8.52e-05	0.00019	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	6.79e-05	0.000151	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	6.34e-05	0.000141	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	5.81e-05	0.00013	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	5.78e-05	0.000129	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	5.74e-05	0.000128	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	5.56e-05	0.000124	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	5.3e-05	0.000118	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	5.07e-05	0.000113	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	3.81e-05	8.5e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	3.5e-05	7.8e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	3.34e-05	7.46e-05	CbGpPWpGaD
